Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-029651
Filing Date
2025-09-23
Accepted
2025-09-23 09:00:09
Documents
1
Period of Report
2025-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5375
  Complete submission text file 0001437749-25-029651.txt   7060
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOCARDIA INC 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address
Altman Peter (Reporting) CIK: 0001647542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38999 | Film No.: 251331870